NEW YORK (Reuters) – Johnson & Johnson will get a new chance to contest the scientific evidence linking talc products to ovarian cancer, a federal judge ruled on Wednesday, potentially disrupting a federal court case that consolidates 53,000 lawsuits.
(Reporting by Dietrich Knauth; Editing by Leslie Adler)
